Antioxidants | Top 5 Most Cited Papers on Liver Disease in 2021
11 May 2022
- “Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy”
Johanna C. Arroyave-Ospina et al.
Antioxidants 2021, 10(2), 174; 10.3390/antiox10020174
Available online: https://www.mdpi.com/2076-3921/10/2/174
- “Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review”
Luca Rinaldi et al.
Antioxidants 2021, 10(2), 270; 10.3390/antiox10020270
Available online: https://www.mdpi.com/2076-3921/10/2/270
- “Changes in Glutathione Content in Liver Diseases: An Update”
Mariapia Vairetti et al.
Antioxidants 2021, 10(3), 364; 10.3390/antiox10030364
Available online: https://www.mdpi.com/2076-3921/10/3/364
- “Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease”
Jacob W. Ballway et al.
Antioxidants 2021, 10(3), 384; 10.3390/antiox10030384
Available online: https://www.mdpi.com/2076-3921/10/3/384
- “Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review”
Paula Fernández-Palanca et al.
Antioxidants 2021, 10(1), 103; 10.3390/antiox10010103
Available online: https://www.mdpi.com/2076-3921/10/1/103